These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Formation of unimer nanoparticles by controlling the self-association of hydrophobically modified poly(amino acid)s. Akagi T; Piyapakorn P; Akashi M Langmuir; 2012 Mar; 28(11):5249-56. PubMed ID: 22385355 [TBL] [Abstract][Full Text] [Related]
63. Impact of the Formulation Pathway on the Colloidal State and Crystallinity of Poly-ε-caprolactone Particles Prepared by Solvent Displacement. Pucci C; Cousin F; Dole F; Chapel JP; Schatz C Langmuir; 2018 Feb; 34(7):2531-2542. PubMed ID: 29356546 [TBL] [Abstract][Full Text] [Related]
64. Physicochemical characterisation of cationic polybutylcyanoacrylate-nanoparticles by fluorescence correlation spectroscopy. Weyermann J; Lochmann D; Georgens C; Rais I; Kreuter J; Karas M; Wolkenhauer M; Zimmer A Eur J Pharm Biopharm; 2004 Jul; 58(1):25-35. PubMed ID: 15207534 [TBL] [Abstract][Full Text] [Related]
65. From nanodroplets by the ouzo effect to interfacial nanolenses. Peng S; Xu C; Hughes TC; Zhang X Langmuir; 2014 Oct; 30(41):12270-7. PubMed ID: 25262570 [TBL] [Abstract][Full Text] [Related]
66. Nanocomposite colloids prepared by the Ouzo effect. Rosenfeld J; Ganachaud F; Lee D J Colloid Interface Sci; 2024 Jan; 653(Pt B):1753-1762. PubMed ID: 37827013 [TBL] [Abstract][Full Text] [Related]
67. Continuous Nanoprecipitation of Polycaprolactone in Additively Manufactured Micromixers. Göttert S; Salomatov I; Eder S; Seyfang BC; Sotelo DC; Osma JF; Weiss CK Polymers (Basel); 2022 Apr; 14(8):. PubMed ID: 35458259 [TBL] [Abstract][Full Text] [Related]
69. Nanoprecipitation as a simple and straightforward process to create complex polymeric colloidal morphologies. Yan X; Bernard J; Ganachaud F Adv Colloid Interface Sci; 2021 Aug; 294():102474. PubMed ID: 34311157 [TBL] [Abstract][Full Text] [Related]
70. Simple elaboration of drug-SPION nanocapsules (hybridosomes®) by solvent shifting: Effect of the drug molecular structure and concentration. Iglicki D; Kahn ML; Goubault C; Blot M; Jarry U; Pedeux R; Le Guével R; Chevance S; Gauffre F Int J Pharm; 2024 Jan; 649():123645. PubMed ID: 38040393 [TBL] [Abstract][Full Text] [Related]
71. Universal nanodroplet branches from confining the Ouzo effect. Lu Z; Schaarsberg MHK; Zhu X; Yeo LY; Lohse D; Zhang X Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10332-10337. PubMed ID: 28894002 [TBL] [Abstract][Full Text] [Related]
72. Synthesis of ultrasmall metal nanoparticles and continuous shells at the liquid/liquid interface in Ouzo emulsions. Gazil O; Virgilio N; Gauffre F Nanoscale; 2022 Sep; 14(37):13514-13519. PubMed ID: 36106947 [TBL] [Abstract][Full Text] [Related]
73. Modulation of Oil/Polymer Nanocapsule Size via Phase Diagram-Guided Microfluidic Coprecipitation. Rosenfeld J; Ganachaud F; Lee D Langmuir; 2023 Apr; 39(15):5477-5485. PubMed ID: 37015180 [TBL] [Abstract][Full Text] [Related]
74. Design Rules for Fluorocarbon-Free Omniphobic Solvent Barriers in Paper-Based Devices. Jahanshahi-Anbuhi S; Pennings K; Leung V; Kannan B; Brennan JD; Filipe CD; Pelton RH ACS Appl Mater Interfaces; 2015 Nov; 7(45):25434-40. PubMed ID: 26496157 [TBL] [Abstract][Full Text] [Related]